(Q40058218)

17 September 2017

Glycogen synthase kinase 3 suppresses myogenic differentiation through negative regulation of NFATc3. (English)

1 reference

17 September 2017

2

Annemie M W J Schols

1 reference

17 September 2017

Jos L J van der Velden

1

1 reference

17 September 2017

Jodil Willems

3

1 reference

17 September 2017

Marco C J M Kelders

4

1 reference

17 September 2017

Ramon C J Langen

5

1 reference

17 September 2017

language of work or name

English

0 references

publication date

31 October 2007

1 reference

Journal of Biological Chemistry

17 September 2017

1 reference

17 September 2017

283

1 reference

17 September 2017

1

1 reference

17 September 2017

358-366

1 reference

Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study

17 September 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707812200

Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707812200

Myonuclear domains in muscle adaptation and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707812200

GSK3 takes centre stage more than 20 years after its discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707812200

Glycogen synthase kinase-3beta is a negative regulator of cardiomyocyte hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707812200

Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707812200

Inhibition of glycogen synthase kinase-3beta activity is sufficient to stimulate myogenic differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707812200

A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707812200

Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707812200

Glycogen synthase kinase-3 inhibits the DNA binding activity of NFATc

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707812200

Delineation of a slow-twitch-myofiber-specific transcriptional element by using in vivo somatic gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707812200

IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707812200

Activation and cellular localization of the cyclosporine A-sensitive transcription factor NF-AT in skeletal muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707812200

Regulation of the growth of multinucleated muscle cells by an NFATC2-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707812200

Altered primary myogenesis in NFATC3(-/-) mice leads to decreased muscle size in the adult

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707812200

Calcineurin signaling and NFAT activation in cardiovascular and skeletal muscle development

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707812200

Calcineurin is required for skeletal muscle hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707812200

Calcineurin-mediated slow-type fiber expression and growth in reloading condition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707812200

A calcineurin-NFATc3-dependent pathway regulates skeletal muscle differentiation and slow myosin heavy-chain expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707812200

NFAT5, a constitutively nuclear NFAT protein that does not cooperate with Fos and Jun

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707812200

Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707812200

Tumor necrosis factor-alpha inhibits myogenic differentiation through MyoD protein destabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707812200

Requirement of nuclear factor of activated T-cells in calcineurin-mediated cardiomyocyte hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707812200

Role of glycogen synthase kinase 3 beta as a negative regulator of dorsoventral axis formation in Xenopus embryos.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707812200

A system for stable expression of short interfering RNAs in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707812200

Stable suppression of tumorigenicity by virus-mediated RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707812200

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707812200

Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707812200

Cellular and molecular regulation of muscle regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707812200

Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707812200

Glycogen synthase kinase-3beta: a novel regulator of cardiac hypertrophy and development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707812200

GSK-3beta negatively regulates skeletal myotube hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707812200

Wnt signaling and the activation of myogenesis in mammals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707812200

Insulin and wnt1 pathways cooperate to induce reserve cell activation in differentiation and myotube hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707812200

Activated glycogen synthase-3 beta suppresses cardiac hypertrophy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707812200

Genomic expression programs and the integration of the CD28 costimulatory signal in T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707812200

Endothelial cells stimulate T cell NFAT nuclear translocation in the presence of cyclosporin A: involvement of the wnt/glycogen synthase kinase-3 beta pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707812200

MyoD, Myf5, and the calcineurin pathway activate the developmental myosin heavy chain genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707812200

Glycogen synthase kinase-3 is the predominant insulin-regulated eukaryotic initiation factor 2B kinase in skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707812200

beta-catenin is a target for the ubiquitin-proteasome pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707812200

21 January 2018

Identifiers

DOI

10.1074/JBC.M707812200

1 reference

17 September 2017

1 reference